IncFact
Company Profiles: Revenue, Growth, Competition

HUMAN GENOME SCIENCES Revenue, Growth & Competitor Profile

Last updated:

Company Awards

Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Human Genome Sciences

Access the complete profile.

Human Genome Sciences Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
EmployeesN/AExact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
6213 Offices of Other Health Practitioners
Address14200 Shady Grove Rd
Rockville, MD 20850

hgsi.com
Note: Revenues for privately held companies are statistical evaluations.


Human Genome Sciences's annual revenues are $100-$500 million (see exact revenue data). It is classified as operating in the Scientific Research & Development Services industry.


Human Genome Sciences's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Human Genome Sciences Annual Revenue and Growth Rate

Human Genome Sciences Revenue Est.
($ Million)
Growth Rate (%)# Employees
2019 Details in Premium Report
2018
2017
2016
2015
2014


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Human Genome Sciences's revenues are gauged from an analysis of company filings.



Human Genome Sciences's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Human Genome Sciences Revenue (Sales) Human Genome Sciences Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Human Genome Sciences is developing and marketing. Human Genome Sciences doesn't have any recent trademark applications, indicating Human Genome Sciences is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
THE US IN LUPUS
Providing information relating to lupus and the treatment of lupus
11/10/2010
LINBELIN
Pharmaceutical preparations for use in promoting the growth and repair of epithelial cells; pharmaceutical preparations for use in the treatment of alimentary tract disorders, allergic conditions, autoimmune diseases, blood disorders, bone diseases and injuries, bone marrow and stem cell transplantation, cardiovascular diseases, central nervous system disorders, connective tissue disorders, ear, nose and throat conditions, endocrinology disorders, gastrointestinal diseases, genetic disease, immunologic conditions, infectious diseases, joint diseases, kidney diseases, liver diseases, metabolic diseases, neurological disorders, nutritional disorders, oncological conditions, ophthalmologic diseases, organ transplantation, pancreatic disorders, respiratory diseases, dermatologic disorders, thrombotic diseases, vascular diseases, tendon and muscular damage, back and joint dysfunction, skin wounds, soft tissue damage and disorders, and inflammation
01/11/2008

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Human Genome Sciences grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Human Genome Sciences is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Scientific Research & Development Services

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Human Genome Sciences's Largest Competitors

A competitive analysis shows these companies are in the same general field as Human Genome Sciences, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
OMNICARECincinnati, OH100 
LEIDOSReston, VA91 
INC RESEARCHMorrisville, NC62 
SCIENCE APPLICATIONS INTERNATIONALReston, VA61 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM47 
CEPHALONFrazer, PA44 
SYNEOS HEALTHRaleigh, NC29 
INCYTEWilmington, DE29 
COVANCEPrinceton, NJ27 




Nearby Competitors

These companies are similar in business line and location to Human Genome Sciences. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
HENRY M. JACKSON FOUNDATION FOR ADVANCEMENT OF MILITARY MEDICINEBethesda, MD100 
OTSUKA AMERICA PHARMACEUTICALRockville, MD95 
SUPERNUS PHARMACEUTICALSRockville, MD67 
PANUM TELECOMPotomac, MD41 
CYSTIC FIBROSIS FOUNDATIONBethesda, MD40 
HUMAN GENOME SCIENCESRockville, MD37 




Future Competition: Human Genome Sciences's Fastest Growing Competitors

These companies are in the same general field as Human Genome Sciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Human Genome Sciences Competitors